Background

Excellence in drug discovery services begins with understanding that each therapeutic target presents unique challenges requiring tailored solutions, and Proteros has built its reputation on successfully addressing these complexities through innovative protein science and structural biology approaches. Our comprehensive service portfolio spans the entire early discovery pipeline, from initial target assessment through qualified hit identification, supported by technologies and expertise that consistently deliver results where others have struggled. We specialise in membrane proteins, challenging enzyme complexes, and other "high hanging fruit" targets that demand sophisticated production and characterisation techniques. Our facility houses dedicated laboratory spaces for structural biology, protein sciences, biologics production, assays development, biophysics, and screening – all designed to maintain the highest standards whilst ensuring rapid project progression. The synergy between our various technology platforms enables us to provide holistic solutions rather than fragmented services, with expert project managers coordinating every aspect to ensure optimal outcomes. Our commitment to scientific excellence, rooted in Nobel prize-winning research foundations, drives continuous innovation in methodologies and instrumentation. This dedication to advancing the field whilst delivering practical solutions has established Proteros as the preferred partner for pharmaceutical and biotechnology companies seeking to accelerate their drug discovery timelines without compromising on quality or reliability.